Healthcare IT Today August 11, 2020
Anne Zieger

If you want an example of how the pandemic is fostering the growth of long-distance medicine, look no further than the following.

Maimonides Medical Center and Meridian Health System have agreed to work with remote diagnostic tech vendor Nanowear to conduct a clinical trial. The goal of the project is to monitor confirmed or suspected COVID-19 patients remotely to detect signs of clinical deterioration.

Nanowear will support the project by providing cloth-based nanosensors. Users wear a one-size-fits-all adjustable undergarment designed to detect physiological and biomarker changes. The Nanowear platform, SimpleSENSE, captures real-time ECG data, systolic and diastolic blood pressure, blood flow hemodynamics, respiration, long volume and fluid, and temperature trends.

As the vendor’s news release states, gathering such data remotely...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health System / Hospital, Patient / Consumer, Provider, Technology
STAT+: Another hospital sues MultiPlan, alleging scheme to ‘suppress’ payments
Integrating Mental and Physical Health to Better Support Patients and Communities
Royal Papworth CIO presents six actions for trusts’ AI journey
Opinion: Solving academic medical centers’ existential crisis
Hospitals Are Using AI To Help Manage Patient Messages to Physicians

Share This Article